首页 > 市场调查报告书 > 製药

个人化医学精神疾病

市场调查报告书

商品编码

1402611

个体化精神病学市场：按类型、治疗领域和地区

Personalized Psychiatry Market, By Type, By Therapeutic Areas, By Region

出版日期: 2023年12月21日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

个体化精神病学市场规模预计将从 2023 年的 41 亿美元增加到 2030 年的 86.8 亿美元，预测期内复合年增长率为 11.3%。

报告范围		报告详情
基准年	2022年	2023年市场规模	41亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	11.30%	2030年市场规模预测	86.8亿美元

图 1. 2023 年个体化精神医学全球市场占有率（按地区划分）

个体化精神病学是精神健康保健领域的一个新领域，旨在改变精神疾病的诊断和治疗方式。传统上，精神病学依赖一刀切的方法，根据广泛的诊断标准为患者开药和治疗方法。个体化精神病学利用每个患者特有的遗传、生物和临床资料来创建针对其心理健康的治疗方法和疗法。个体化精神病学旨在用更有针对性和客製化的策略取代一刀切的策略。使用的一些关键技术包括穿戴式生物感测器、电脑化治疗程序、定量脑电图、药物基因组测试和分子诊断。人们对心理健康问题认识的提高、神经生物学和基因组学的进步以及对更好的心理健康诊断和治疗结果的需求是推动市场的关键因素。

市场动态：

由于数位健康技术的快速进步、基因组学、穿戴式装置和行动应用程式的创新等几个关键因素，个体化精神病学市场预计将在未来几年显着成长。此外，心理健康评估和治疗领域的人工智慧也有望在预测期内推动市场成长。这些技术可以实现即时资料收集，使临床医生能够远端监控患者并做出资讯的护理决策。

然而，个体化精神病学市场也面临一些挑战。阻碍因素因素之一是实施个体化方法的高成本。开发和实施先进技术可能成本高昂，而且这些服务的报销选项可能有限。此外，在精神健康保健中使用资料和数数位资料还存在监管和伦理方面的考虑，这可能会延迟个体化方法的采用。

本研究的主要特点

本报告对全球个体化心理健康护理市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年增长率。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球个体化精神病学市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
全球个体化精神病学市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球个体化精神病学市场的各种策略矩阵，将有助于相关人员做出决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.10 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	11.30%	2030 Value Projection:	US$ 8.68 Bn

Personalized psychiatry is an emerging field within the realm of mental healthcare that aims to revolutionize the way mental illnesses are diagnosed and treated. Traditionally, psychiatry has relied on a one-size-fits-all approach, where patients are prescribed medications or therapies based on broad diagnostic criteria. Using individual patient-specific genetic, biological, and clinical data, personalized psychiatry creates specialized mental health treatments and therapies. It seeks to replace the one-size-fits-all strategy with a more focused, customized one. Among the important technologies utilized are wearable biosensors, computerized therapy programs, quantitative EEG, pharmacogenomic testing, and molecular diagnostics. Growing public awareness of mental health issues, developments in neurobiology and genomics, and the need for better mental health diagnosis and treatment outcomes are the primary factors propelling the market.

Market Dynamics:

The personalized psychiatry market is expected to witness significant growth in the coming years, driven by several key factors such as rapid advancement of digital health technologies, innovations in genomics, wearables, and mobile apps. In addition, artificial intelligence in the field of mental health assessment and treatment is also expected to drive market growth over the forecast period. These technologies enable the collection of real-time data, allowing clinicians to monitor patients remotely and make informed decisions about their care.

However, the personalized psychiatry market also faces some challenges. One of the main restraints is the high cost associated with implementing personalized approaches. Developing and deploying advanced technologies can be expensive, and there may be limited reimbursement options for these services. Furthermore, there are regulatory and ethical considerations surrounding the use of genetic and digital data in mental healthcare, which may slow down the adoption of personalized approaches.

Key features of the study:

This report provides in-depth analysis of the global personalized psychiatry market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized psychiatry market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GreyBird Ventures, Sunovion Pharmaceuticals Inc., HMNC Holding GmbH, Arcara Personalized Psychiatry, Starling Minds, Karuna Therapeutics, CBT Plus, AltheaDx, Inc., WayForward, BrightQuest, Peak Mental Wellness
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized psychiatry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized psychiatry market

Detailed Segmentation:

By Type:
- Products
- Diagnostics
- Therapeutics
- Services
- Software
By Therapeutic Areas:
- Depression
- Anxiety
- Bipolar Disorder
- Schizophrenia
- Addiction
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Top companies in Personalized Psychiatry Market:
- GreyBird Ventures
- Sunovion Pharmaceuticals Inc.
- HMNC Holding GmbH
- Arcara Personalized Psychiatry
- Starling Minds
- Karuna Therapeutics
- CBT Plus
- AltheaDx, Inc.
- WayForward
- BrightQuest
- Peak Mental Wellness

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Personalized Psychiatry, By Type
- Market Personalized Psychiatry, By Therapeutic Areas
- Market Personalized Psychiatry, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing need for improved diagnosis and treatment outcomes in mental healthcare
- Rising prevalence of mental disorders
- Growing adoption of precision medicine model in healthcare
Restraints
Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Personalized Psychiatry Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Personalized Psychiatry Market , By Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Diagnostics
Therapeutics
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Personalized Psychiatry Market , By Therapeutic Areas, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Bipolar Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Schizophrenia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Personalized Psychiatry Market , By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Areas, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

GreyBird Ventures
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sunovion Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HBNC Holding GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arcara Personalized Psychiatry
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Starling Minds
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Karuna Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CBT Plus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AltheaDx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WayForward
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BrightQuest
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Peak Mental Wellness
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

个体化精神病学市场：按类型、治疗领域和地区